Inspire Medical Reports Strong Q3 Growth and Raises Outlook
Company Announcements

Inspire Medical Reports Strong Q3 Growth and Raises Outlook

Inspire Medical ( (INSP) ) has released its Q3 earnings. Here is a breakdown of the information Inspire Medical presented to its investors.

Inspire Medical Systems, Inc. is a medical technology company dedicated to developing minimally invasive solutions for patients with obstructive sleep apnea.

In its latest earnings report for the third quarter of 2024, Inspire Medical Systems announced a significant 33% revenue increase year-over-year and earnings per share of $0.60. The company also highlighted the FDA approval of its Inspire V neurostimulation system and the expansion of its U.S. sales territories and medical centers.

Key financial metrics for the third quarter include a revenue of $203.2 million and a gross margin of 84.1%. The company reported an operating income of $14.3 million, a notable improvement from the previous year’s operating loss. Inspire also increased its cash and cash equivalents to $524.4 million by the end of the quarter.

Looking ahead, Inspire Medical Systems is optimistic about its growth prospects, raising its full-year revenue guidance to between $793 million and $798 million and increasing its earnings per share guidance. The company continues to focus on expanding its market presence and enhancing the adoption of its therapy for sleep apnea patients.

Related Articles
TipRanks Auto-Generated NewsdeskInspire Medical Systems Sees Strong Q3 Growth in 2024
TheFlyInspire Medical raises FY24 EPS view to $1.20-$1.40 from 60c-80c
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App